Precision Medicine, Group Technology and Research

Focusing DNV GL’s expertise to improve safety and quality in healthcare by enabling precision medicine in clinical work.
Precision Medicine

DNV GL’s Precision Medicine works with partners through large-scale public-private research and innovation projects to help address the data-sharing and infrastructure needs, legal and regulatory challenges, and gaps in trust that prevent the clinical implementation of big data approaches, AI tools, and precision medicine in routine clinical care.

Building quality & assurance in precision medicine

New technologies must fulfill appropriate safety and quality requirements before clinical adoption.

Trust in data-driven medicine

Artificial intelligence is increasingly impacting how health systems make decisions and deliver care.

Dynamic consent in clinical genetics

We work with experts from healthcare institutions, legal and academia to identify barriers to implementation of dynamic consent, and focus on coordinating efforts to make dynamic consent a reality in clinical genetics environments

Publications

The latest position papers and reports from our strategic research precision medicine programme

Contact us to learn more:

Bobbie Nicole Ray-Sannerud
Bobbie Nicole Ray-Sannerud

Program Director, Precision Medicine Group Technology and Research

Send email